Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td align="left" rowspan="2">lncRNA</td><td align="center" rowspan="2">Healthy control</td><td align="center" colspan="3">HCC</td></tr><tr class="thead"><td align="center">I-II</td><td align="center">II-III</td><td align="center">III-IV</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td align="left">HULC</td><td align="center">2/20 (10%)</td><td align="center">1/7 (14%)</td><td align="center">8/13 (62%)</td><td align="center">10/10 (100%)</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

HULC in the plasma of healthy controls and HCC patients.

BioMed Research International

tab2

Table 2

Table 2: Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma 